Pay in 4 interest-free payments of $44.62 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
High-Throughput Virtual Screening Identifies Novel N'-(1-Phenylethylidene)-benzohydrazides as Potent
Treatment of primary colorectal cancer xenografts with the small-molecule BMI-1 inhibitor PTC-209 resulted in colorectal CIC loss with long-term and irreversible impairment of tumor growth
Chemical Name: 6-(prop-2-en-1-yl)-4H
Anna PlanagumÃ
Reparixin - CAS# 266359-83-5 10208 High-Throughput Virtual Screening Identifies NovelReparixin is an inhibitor of CXCR2 function, which attenuates inflammatory responses and promotes recovery of function after traumatic lesion to the spinal cord. In a human breast cancer cell line, both reparixin reduced the number of breast cancer stem cells compared with no treatment. I n mice with primary human breast cancer xenografts, reparixin alone or in combination with docetaxel reduced tumor growth compared with saline control. The
US$ 21.95
US$ 21.95
US$ 21.95
US$ 147.50
US$ 37.90
US$ 135.00
US$ 11749.50
US$ 25.00
US$ 30.00
US$ 12.75